Santhera Pharmaceuticals Holding AG (SWX: SANN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
9.18
-0.11 (-1.18%)
Sep 4, 2024, 1:00 PM CET
9.29%
Market Cap 108.88M
Revenue (ttm) 103.41M
Net Income (ttm) 54.78M
Shares Out 11.72M
EPS (ttm) 5.01
PE Ratio 1.85
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,765
Open 9.28
Previous Close 9.29
Day's Range 9.18 - 9.35
52-Week Range 7.14 - 14.62
Beta 0.12
Analysts n/a
Price Target n/a
Earnings Date Sep 12, 2024

About SANN

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceutic... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 45
Stock Exchange SIX Swiss Exchange
Ticker Symbol SANN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.